Publication

Abstract : The accurate prediction based on lung auscultation of respiratory obstruction conditions (ROC), such as chronic obstructive pulmonary disease (COPD) and asthma, is a challenging task due to the availability of small datasets, ambient noise, variability between patients, high computational power, overlapping auscultation characteristics and lack of universal clinical standards. Secondly, discrimination of obstructive respiratory diseases (COPD, asthma) and restrictive respiratory diseases (other) is critical, as they have different treatment and management strategies. Third, a clear distinction between COPD and asthma is of great concern, as treatment at the appropriate stage results in an open air passage in COPD and an improvement in shortness of breath in asthma. Although several techniques have been explored for diagnosing respiratory disease based on lung auscultation, there is still a need for an effective, low-cost, and faster solution suitable for real-time ROC detection. The time-frequency representations of audio signals are suitable to capture low-frequency information, as well as tonal and harmonic relationships. In contrast, deep learning architectures can learn complex, hierarchical, and high-level patterns from the spatio-temporal structures. In addition, extreme learning machines (ELM) can provide generalized performance with fewer training parameters. Hence, combining time-frequency representations, deep learning architecture, and ELM would result in the most reliable low-cost tool to predict ROC from lung auscultation. The fusion of deep features from different spatiotemporal structures outperforms individual features when fed into the ELM model, resulting in clear discrimination of obstructive and restrictive respiratory diseases. The proposed CNN-enhanced time-frequency features powered the ELM-based framework, yielding a test accuracy of 97 5% for the unseen test data considered. Thus, this study would be a useful aid for pulmonologists and would play a pivotal role in the accessibility to healthcare, early intervention, and long-term management of ROC disease.